Research Spotlight: Novel Therapy Blocks Glioblastoma’s Immune System

Research Spotlight: Novel Therapy Blocks Glioblastoma’s Immune System

In a breakthrough study that could reshape therapeutic approaches to one of the most lethal brain cancers, researchers have uncovered a cunning mechanism by which glioblastoma (GBM) manipulates the brain’s immune environment to evade destruction. Glioblastoma, known for its aggressive nature and resistance to conventional therapies, has long baffled scientists, particularly because immune-based treatments that have transformed outcomes in other …

Alpheus Medical Raises $52M in Series B Round to Advance Groundbreaking Glioblastoma Therapy

Funding will support a randomized Phase 2B study of the novel sonodynamic therapy in patients with newly diagnosed glioblastoma  CHANHASSEN, Minn., May 15, 2025 /PRNewswire/ — Alpheus Medical, Inc., a private, clinical-stage oncology company pioneering sonodynamic therapy (SDT) for the treatment of solid body cancers, today announced the closing of an oversubscribed $52 million Series B financing round. The funds will support a Phase 2B randomiz…